Apigenin inhibits renal cell carcinoma cell proliferation

Oncotarget

Volumn 8, Issue 12, 2017, Pages 19834-19842

  Meng, Shuai ^a   Zhu, Yi ^a   Li, Jiang Feng ^a   Wang, Xiao ^a   Liang, Zhen ^a   Li, Shi Qi ^a   Xu, Xin ^a   Chen, Hong ^a   Liu, Ben ^a   Zheng, Xiang Yi ^a   Xie, Li Ping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apigenin; Apoptosis; ATM signaling; DNA damage; Renal cell carcinoma

Indexed keywords

APIGENIN; ATM PROTEIN; ATR PROTEIN; CASPASE 3; CASPASE 9; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN P53; SMALL INTERFERING RNA;

786 0 CELL LINE; ACHN CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; CAKI 1 CELL LINE; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL LINE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; ERYTHROCYTE COUNT; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; LEUKOCYTE COUNT; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, RENAL CELL; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; FLUORESCENCE MICROSCOPY; GENETICS; KIDNEY NEOPLASMS; METABOLISM; NUDE MOUSE; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APIGENIN; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; COMET ASSAY; DNA DAMAGE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, FLUORESCENCE; RNA INTERFERENCE; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85015755933     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.15771     Document Type: Article

References (40)

1. Miean KH, Mohamed S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem. 2001; 49:3106-3112.
2. Zhu Y, Wu J, Li S, Wang X, Liang Z, Xu X, Xu X, Hu Z, Lin Y, Chen H, Qin J, Mao Q, Xie L. Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer. Mol Med Rep. 2015; 11:1004-1008.
3. Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, Dhananjaya BL, Dowluru KS, Chintala R, Duddukuri GR. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016.
4. Yin F, Giuliano AE, Law RE, Van Herle AJ. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 2001; 21:413-420.
5. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF. Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 2000; 28:102-110.
6. Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells. Pharmacol Toxicol. 2000; 86:83-91.
7. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 2000; 87:595-600.
8. Farooqi AA, Wu SJ, Chang YT, Tang JY, Li KT, Ismail M, Liaw CC, Li RN, Chang HW. Activation and Inhibition of ATM by Phytochemicals: Awakening and Sleeping the Guardian Angel Naturally. Arch Immunol Ther Exp (Warsz). 2015; 63:357-366.
9. Czeczot H, Tudek B, Kusztelak J, Szymczyk T, Dobrowolska B, Glinkowska G, Malinowski J, Strzelecka H. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat Res. 1990; 240:209-216.
10. Smaletz O. Current management and future directions in the treatment of advanced renal cell carcinoma-a latin american perspective: 10 years in review. Int Braz J Urol. 2015; 41:835-843.
11. Bhatt JR, Finelli A. Landmarks in the diagnosis and treatment of renal cell carcinoma. Nat Rev Urol. 2014; 11:517-525.
12. Newman DJ, Cragg GM. Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79:629-661.
13. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 2003; 3:768-780.
14. Kim A, Nam YJ, Lee MS, Shin YK, Sohn DS, Lee CS. Apigenin Reduces Proteasome Inhibition-Induced Neuronal Apoptosis by Suppressing the Cell Death Process. Neurochem Res. 2016.
15. Balez R, Steiner N, Engel M, Munoz SS, Lum JS, Wu Y, Wang D, Vallotton P, Sachdev P, O'Connor M, Sidhu K, Munch G, Ooi L. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease. Sci Rep. 2016; 6:31450.
16. Chanput W, Krueyos N, Ritthiruangdej P. Anti-oxidative assays as markers for anti-inflammatory activity of flavonoids. Int Immunopharmacol. 2016; 40:170-175.
17. Bridgeman BB, Wang P, Ye B, Pelling JC, Volpert OV, Tong X. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention. Cell Signal. 2016; 28:460-468.
18. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001; 21:381-406.
19. Liu-Smith F, Meyskens FL. Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma. Mol Nutr Food Res. 2016; 60:1264-1274.
20. O'Prey J, Brown J, Fleming J, Harrison PR. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem Pharmacol. 2003; 66:2075-2088.
21. Thiery-Vuillemin A, Nguyen T, Pivot X, Spano JP, Dufresnne A, Soria JC. Molecularly targeted agents: their promise as cancer chemopreventive interventions. Eur J Cancer. 1990). 2005; 41:2003-2015.
22. Sharma H, Kanwal R, Bhaskaran N, Gupta S. Plant flavone apigenin binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells. PLoS One. 2014; 9:e91588.
23. Zhang L, Cheng X, Gao Y, Zheng J, Xu Q, Sun Y, Guan H, Yu H, Sun Z. Apigenin induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells. Food Funct. 2015; 6:3464-3472.
24. Fang J, Bao YY, Zhou SH, Fan J. Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1. Mol Med Rep. 2015; 12:6461-6466.
25. Lim W, Park S, Bazer FW, Song G. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways. J Cell Physiol. 2016.
26. Shukla S, Bhaskaran N, Babcook MA, Fu P, Maclennan GT, Gupta S. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway. Carcinogenesis. 2014; 35:452-460.
27. Maggioni D, Garavello W, Rigolio R, Pignataro L, Gaini R, Nicolini G. Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis. Int J Oncol. 2013; 43:1675-1682.
28. Li LH, Lu B, Wu HK, Zhang H, Yao FF. Apigenin inhibits TGFbeta1-induced proliferation and migration of airway smooth muscle cells. Int J Clin Exp Pathol. 2015; 8:12557-12563.
29. Hu W, Wang X, Wu L, Shen T, Ji L, Zhao X, Si CL, Jiang Y, Wang G. Apigenin-7-O-beta-D-glucuronide inhibits LPSinduced inflammation through the inactivation of AP-1 and MAPK signaling pathways in RAW 264.7 macrophages and protects mice against endotoxin shock. Food Funct. 2016; 7:1002-1013.
30. Shukla S, Kanwal R, Shankar E, Datt M, Chance MR, Fu P, MacLennan GT, Gupta S. Apigenin blocks IKKalpha activation and suppresses prostate cancer progression. Oncotarget. 2015; 6:31216-31232. doi: 10.18632/oncotarget.5157.
31. Yin F, Giuliano AE, Van Herle AJ. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). Anticancer Res. 1999; 19:4297-4303.
32. Takagaki N, Sowa Y, Oki T, Nakanishi R, Yogosawa S, Sakai T. Apigenin induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway. Int J Oncol. 2005; 26:185-189.
33. Banerjee K, Mandal M. Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Redox Biol. 2015; 5:153-162.
34. Seydi E, Rasekh HR, Salimi A, Mohsenifar Z, Pourahmad J. Selective Toxicity of Apigenin on Cancerous Hepatocytes by Directly Targeting their Mitochondria. Anticancer Agents Med Chem. 2016; 16:1576-1586.
35. Lim W, Park S, Bazer FW, Song G. Apigenin Reduces Survival of Choriocarcinoma Cells by Inducing Apoptosis via the PI3K/AKT and ERK1/2 MAPK Pathways. J Cell Physiol. 2016; 231:2690-2699.
36. Kobayashi T, Nakata T, Kuzumaki T. Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett. 2002; 176:17-23.
37. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015; 67:913-924.
38. Osada M, Imaoka S, Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett. 2004; 575:59-63.
39. Zhao M, Ma J, Zhu HY, Zhang XH, Du ZY, Xu YJ, Yu XD. Apigenin inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90. Mol Cancer. 2011; 10:104.
40. Guimaraes R, Calhelha RC, Froufe HJ, Abreu RM, Carvalho AM, Queiroz MJ, Ferreira IC. Wild Roman chamomile extracts and phenolic compounds: enzymatic assays and molecular modelling studies with VEGFR-2 tyrosine kinase. Food Funct. 2016; 7:79-83.